Chad Seaver is a MedTech executive and entrepreneur with over twenty years of experience commercializing medical devices and biotech breakthroughs. He is currently CEO and Board Manager of medical imaging startup Cintilight. He also serves as a member of the Board of Directors of Rhaeos and as an advisor to several med- and biotech companies.
Chad was formerly co-founder and CEO of Knoxville-based startup Arkis BioSciences, a neurosurgical device company. He led the commercialization of the company’s groundbreaking Endexo® catheter technology and minimally invasive guidewire instrumentation for advancing hydrocephalus shunt treatments. Integra LifeSciences acquired Arkis BioSciences in July 2019.
He graduated from the University of Tennessee, earning a Ph.D. in biomedical engineering and master’s and bachelor’s degrees in electrical engineering.